These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25937322)

  • 1. Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAs.
    Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Scherman D; Escriou V; Arbuthnot P
    J Control Release; 2015 Jul; 209():198-206. PubMed ID: 25937322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2'-O-guanidinopropyl modified siRNAs.
    Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Arbuthnot P
    Bioorg Med Chem; 2013 Oct; 21(20):6145-55. PubMed ID: 23743442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
    Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
    Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.
    Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW
    Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo.
    Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D
    Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice.
    Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
    Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
    J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Countering hepatitis B virus infection using RNAi: how far are we from the clinic?
    Ivacik D; Ely A; Arbuthnot P
    Rev Med Virol; 2011 Nov; 21(6):383-96. PubMed ID: 21913277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties.
    Peng J; Zhao Y; Mai J; Pang WK; Wei X; Zhang P; Xu Y
    J Gen Virol; 2005 Dec; 86(Pt 12):3227-3234. PubMed ID: 16298967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs.
    Uprichard SL; Boyd B; Althage A; Chisari FV
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):773-8. PubMed ID: 15640346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
    Xuan B; Qian Z; Hong J; Huang W
    Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA.
    Chen CC; Ko TM; Ma HI; Wu HL; Xiao X; Li J; Chang CM; Wu PY; Chen CH; Han JM; Yu CP; Jeng KS; Hu CP; Tao MH
    Gene Ther; 2007 Jan; 14(1):11-9. PubMed ID: 16929350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes.
    Crowther C; Mowa MB; Ely A; Arbuthnot PB
    Antivir Ther; 2014; 19(4):363-73. PubMed ID: 24296696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.